4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-21-037323
Options or other derivatives
- Director sold 152,870 shares at an average $0.29 ($45,020)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| NEIS JOHN Director | 2021-03-12 | Sale · Series A Warrants | −41,155 | $0.27 | $10,980 | 193,587 | D |
| NEIS JOHN Director | 2021-03-15 | Sale · Series A Warrants | −11,200 | $0.27 | $2,970 | 182,387 | D |
| NEIS JOHN Director | 2021-03-16 | Sale · Series A Warrants | −100,515 | $0.31 | $31,069 | 81,872 | D |
Loading xslF345X03/tm2110008d1_4.xml…